Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Mar-24 6:45 PM View:  | Revance Therapeutics, Inc. (RVNC) | 18-Mar-24 | Sale | 9,211 | $5.04 | $46,446.50 | (5%) 176.76K to 167.55K | |
| 19-Mar-24 6:45 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Mar-24 | Payment of Exercise | 2,967 | $5.30 | $15,739.90 | (2%) 179.73K to 176.76K | |
| 04-Mar-24 5:34 PM View: | Revance Therapeutics, Inc. (RVNC) | 29-Feb-24 | Grant | 22,110 | -- | -- | 14% 157.62K to 179.73K | |
| 03-Jan-24 4:50 PM View: | Revance Therapeutics, Inc. (RVNC) | 31-Dec-23 | Grant | 264 | $7.47 | $1,972.08 | < 1% 157.35K to 157.62K | |
| 18-Dec-23 4:32 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Dec-23 | Payment of Exercise | 4,712 | $8.08 | $38,073.00 | (3%) 162.07K to 157.35K | |
| 15-Aug-23 4:15 PM View: | Revance Therapeutics, Inc. (RVNC) | 11-Aug-23 | Grant | 22,620 | -- | -- | 15% 148.35K to 170.97K | |
| 15-Aug-23 4:15 PM View: | Revance Therapeutics, Inc. (RVNC) | 11-Aug-23 | Payment of Exercise | 8,901 | $18.91 | $168,318.00 | (5%) 170.97K to 162.07K | |
| 05-Jul-23 10:00 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Jun-23 | Grant | 1,000 | $15.61 | $15,606.00 | < 1% 147.35K to 148.35K | (1%) |
| 13-Jun-23 10:00 PM View: | Revance Therapeutics, Inc. (RVNC) | 09-Jun-23 | Private Sale (Planned) | 5,000 | $30.82 | $154,096.00 | (3%) 152.35K to 147.35K | |
| 16-May-23 8:29 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-May-23 | Sale | 21,015 | $34.55 | $726,003.00 | (12%) 173.36K to 152.35K | |
| 17-Mar-23 3:21 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Mar-23 | Payment of Exercise | 2,967 | $30.65 | $90,938.50 | (2%) 123.93K to 120.97K | |
| 09-Mar-23 10:00 PM View: | Revance Therapeutics, Inc. (RVNC) | 09-Mar-23 | Sale | 21,508 | $31.59 | $679,358.00 | (15%) 145.44K to 123.93K | |
| 16-Feb-23 8:29 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Feb-23 | Payment of Exercise | 2,766 | $33.21 | $91,858.90 | (3%) 95.81K to 93.05K | |
| 03-Jan-23 4:28 PM View: | Revance Therapeutics, Inc. (RVNC) | 31-Dec-22 | Grant | 605 | $12.18 | $7,369.20 | < 1% 95.21K to 95.81K | |
| 16-Dec-22 4:11 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Dec-22 | Payment of Exercise | 2,916 | $21.50 | $62,694.00 | (3%) 98.12K to 95.21K | |
| 09-Mar-23 10:00 PM View: | Revance Therapeutics, Inc. (RVNC) | 22-Sep-22 | Grant | 52,396 | -- | -- | 56% 93.05K to 145.44K | |
| 05-Jul-22 6:15 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Jun-22 | Grant | 1,000 | $11.75 | $11,747.00 | 1% 97.12K to 98.12K | |
| 17-Mar-22 5:43 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Mar-22 | Payment of Exercise | 1,835 | $15.79 | $28,974.70 | (2%) 98.96K to 97.12K | 2% |
| 17-Feb-22 8:54 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Feb-22 | Payment of Exercise | 2,429 | $13.35 | $32,427.20 | (2%) 101.39K to 98.96K | |
| 16-May-23 8:29 PM View: | Revance Therapeutics, Inc. (RVNC) | 02-Feb-22 | Grant | 52,395 | -- | -- | 43% 120.97K to 173.36K | |
| 17-Dec-21 5:29 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Dec-21 | Payment of Exercise | 513 | $15.92 | $8,166.96 | (< 1%) 101.9K to 101.39K | (< 1%) |
| 10-Nov-21 8:32 PM View: | Revance Therapeutics, Inc. (RVNC) | 09-Nov-21 | Grant | 35,920 | -- | -- | 54% 65.98K to 101.9K | |
| 02-Jul-21 7:56 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Jun-21 | Acquisition (other) | 882 | $24.09 | $21,246.50 | 1% 65.1K to 65.98K | |
| 16-Apr-21 10:00 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Apr-21 | Payment of Exercise | 411 | $28.16 | $11,573.80 | (< 1%) 65.51K to 65.1K | 0% |
| 19-Feb-21 8:13 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Feb-21 | Payment of Exercise | 2,410 | $28.97 | $69,817.70 | (4%) 67.92K to 65.51K | 3% |
| 04-Feb-21 9:16 PM View: | Revance Therapeutics, Inc. (RVNC) | 02-Feb-21 | Grant | 22,620 | -- | -- | 50% 45.3K to 67.92K | |
| 04-Jan-21 7:59 PM View: | Revance Therapeutics, Inc. (RVNC) | 31-Dec-20 | Acquisition (other) | 348 | $21.36 | $7,433.45 | < 1% 44.95K to 45.3K | |
| 22-Dec-20 8:37 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Dec-20 | Payment of Exercise | 562 | $26.75 | $15,033.50 | (1%) 45.51K to 44.95K | (3%) |
| 02-Oct-20 8:34 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Sep-20 | Grant | 17,500 | -- | -- | 51% 34.06K to 51.56K | |
| 02-Oct-20 8:34 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Sep-20 | Payment of Exercise | 6,051 | $25.14 | $152,122.00 | (12%) 51.56K to 45.51K | (10%) |
| 02-Jul-20 8:20 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Jun-20 | Acquisition (other) | 1,000 | $13.80 | $13,795.50 | 3% 33.06K to 34.06K | |
| 17-Apr-20 7:51 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Apr-20 | Payment of Exercise | 432 | $14.80 | $6,393.60 | (1%) 33.5K to 33.06K | (86%) |
| 19-Feb-20 8:20 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Feb-20 | Payment of Exercise | 288 | $25.33 | $7,295.04 | (< 1%) 33.78K to 33.5K | (9%) |
| 24-Jan-20 8:18 PM View: | Revance Therapeutics, Inc. (RVNC) | 23-Jan-20 | Grant | 20,000 | -- | -- | 145% 13.78K to 33.78K | |
| 03-Jan-20 6:48 PM View: | Revance Therapeutics, Inc. (RVNC) | 31-Dec-19 | Acquisition (other) | 382 | $10.82 | $4,133.24 | 3% 13.4K to 13.78K | 1% |
| 17-Dec-19 8:00 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Dec-19 | Payment of Exercise | 576 | $15.99 | $9,210.24 | (5%) 12.07K to 11.49K | (73%) |